Patents by Inventor Toshiaki Oda
Toshiaki Oda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8914231Abstract: A mobile-side terminal apparatus of the present invention includes: a route information storing unit that stores route information related to a route that a user follows; a position acquiring unit that acquires a present position of the user; a display unit that displays the route information stored in the route information storing unit and the present position acquired by the position acquiring unit; and a position transmitting unit that performs transmission of the present position acquired by the position acquiring unit to another information processing device that stores the route information and displays the route information and the present position.Type: GrantFiled: May 6, 2011Date of Patent: December 16, 2014Assignee: Lenovo Innovations Limited (Hong Kong)Inventor: Toshiaki Oda
-
Publication number: 20130046460Abstract: A mobile-side terminal apparatus of the present invention includes: a route information storing unit that stores route information related to a route that a user follows; a position acquiring unit that acquires a present position of the user; a display unit that displays the route information stored in the route information storing unit and the present position acquired by the position acquiring unit; and a position transmitting unit that performs transmission of the present position acquired by the position acquiring unit to another information processing device that stores the route information and displays the route information and the present position.Type: ApplicationFiled: May 6, 2011Publication date: February 21, 2013Applicant: NEC CORPORATIONInventor: Toshiaki Oda
-
Patent number: 7858615Abstract: The present invention is directed to (S)-(?)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate, to a method producing the dihydrate, and to a drug composition containing the dihydrate. The compound of the present invention has less hygroscopicity as compared with (S)-(?)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride anhydrous crystals and thus, exhibits excellent chemical stability.Type: GrantFiled: November 29, 2005Date of Patent: December 28, 2010Assignees: Kowa Co., Ltd., D. Western Therapeutics Institute, Inc.Inventors: Takeshi Ohshima, Hiroyoshi Hidaka, Masami Shiratsuchi, Kazuhiro Onogi, Toshiaki Oda
-
Publication number: 20100261933Abstract: A method for conveniently preparing 2,2-dichloro-12-(4-chlorophenyl)-10-hydroxydodecanoic acid useful as an active ingredient of therapeutic agents for diseases such as diabetes at a high yield, which comprises the step of reacting a compound represented by the following general formula (A): wherein X represents a halogen atom, and a compound represented by the following general formula (B): CHCl2COOR1 wherein R1 represents hydrogen atom or a protective group of carboxyl group, to prepare a compound represented by the following general formula (C): wherein R1 has the same meaning as that defined above.Type: ApplicationFiled: March 29, 2007Publication date: October 14, 2010Applicant: KOWA COMPANY, LTD.Inventors: Manabu Katsurada, Yasuko Nakajima, Yuzo Kasuga, Kazuhiro Onogi, Toshiaki Oda
-
Publication number: 20080021018Abstract: The present invention is directed to (S)-(?)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate, to a method producing the dihydrate, and to a drug composition containing the dihydrate. The compound of the present invention has less hygroscopicity as compared with (S)-(?)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride anhydrous crystals and thus, exhibits excellent chemical stability.Type: ApplicationFiled: November 29, 2005Publication date: January 24, 2008Applicants: Kowa Co., Ltd, D. Western Therapeutics Institute, Inc.Inventors: Takeshi Ohshima, Hiroyoshi Hidaka, Masami Shiratsuchi, Kazuhiro Onogi, Toshiaki Oda
-
Patent number: 7149937Abstract: An information processing method is provided which allows each shop in a cyber shopping site to continue its operation even if some errors of merchandise data are found in each of a plurality of data processes. More specifically, an error rate of input merchandise data is calculated at each process, and if the error rate is equal to or larger than a data error allowable threshold value, the next process is performed in order to continue the operation of the shop.Type: GrantFiled: January 16, 2003Date of Patent: December 12, 2006Assignee: Hitachi, Ltd.Inventors: Toshiaki Oda, Hiroyoshi Tsuchiya, Junichiro Takagi
-
Patent number: 7135473Abstract: A cyclic diamine compound of formula (1): wherein R1 and R2 are individually a hydrogen atom or a methoxy group, provided R1 is a methoxy group when R2 is a hydrogen atom, or a hydrogen atom when R2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH?CH, CH?N or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR4, in which R4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.Type: GrantFiled: August 13, 2003Date of Patent: November 14, 2006Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Takeshi Doi, Yoshinori Kyotani
-
Publication number: 20050176764Abstract: Abstract The present invention is directed to a method for treating cancer, a method for inhibiting histone deacetylase, and a method for facilitating gene therapy, comprising administering an effective amount of a cyclic amine compound represented by the following formula (1):(wherein R1, R2, and R3 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkyl group, a halogen-substituted alkyl group, an alkoxy group, an alkylthio group, a carboxyl group, an alkoxycarbonyl group, or an alkanoyl group; W1 and W2, which are identical to or different from each other, represent N or CH; X represents O, NR4, CONR4, or NR4CO; R4 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted heteroaralkyl group; and l, m, and n each represent a number of 0 or 1), a salt thereof, or a hydrate thereof.Type: ApplicationFiled: April 11, 2003Publication date: August 11, 2005Applicant: KOWA CO., LTDInventors: Chikage Mataki, Tatsuhiko Kodama, Takeshi Doi, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Masao Ohkuch
-
Patent number: 6867221Abstract: A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group; W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.Type: GrantFiled: July 10, 2002Date of Patent: March 15, 2005Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Takeshi Doi, Yoshinori Kyotani, Masao Ohkuchi
-
Publication number: 20040058913Abstract: A cyclic diamine compound of formula (1): 1Type: ApplicationFiled: August 13, 2003Publication date: March 25, 2004Applicant: KOWA CO., LTD.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Takeshi Doi, Yoshinori Kyotani
-
Publication number: 20040010147Abstract: A cyclic amine compound represented by the following general formula (1): 1Type: ApplicationFiled: July 10, 2002Publication date: January 15, 2004Applicant: KOWA CO., LTD.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Takeshi Doi, Yoshinori Kyotani, Masao Ohkuchi
-
Patent number: 6632810Abstract: A cyclic diamine compound of formula (1): wherein R1 and R2 are individually a hydrogen atom or a methoxy group, provided R1 is a methoxy group when R2 is a hydrogen atom, or a hydrogen atom when R2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH═CH, CH═N or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR4, in which R4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.Type: GrantFiled: June 29, 2001Date of Patent: October 14, 2003Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Takeshi Doi, Yoshinori Kyotani
-
Patent number: 6621903Abstract: The pitch name of one musical note in a desired incoming call reporting melody is input through a voice (step S2). The input voiced pitch name information is subjected to speech recognition, and pitch name data, which matches data representing the input pitch name, is selected from a plurality of previously cataloged pitch name data (step S3) Next, the pitch name based on the selected one pitch name data is displayed as a character on a display screen, and the note duration of the pitch name is keyed (steps S4 and S5). A musical note corresponding to the musical note data thus obtained is displayed on a musical staff on the screen (step S6). One score data comprising a plurality of musical note data prepared in the same manner as described above is stored in a storage unit (step S8). At the time of inputting a chord, in the step S2, the pitch names of a plurality of respective musical notes constituting one chord are successively input through a voice.Type: GrantFiled: March 20, 2001Date of Patent: September 16, 2003Assignee: NEC CorporationInventor: Toshiaki Oda
-
Publication number: 20030158787Abstract: An information processing method is provided which allows each shop in a cyber shopping site to continue its operation even if some errors of merchandise data are found in each of a plurality of data processes. More specifically, an error rate of input merchandise data is calculated at each process, and if the error rate is equal to or larger than a data error allowable threshold value, the next process is performed in order to continue the operation of the shop.Type: ApplicationFiled: January 16, 2003Publication date: August 21, 2003Inventors: Toshiaki Oda, Hiroyoshi Tsuchiya, Junichiro Takagi
-
Patent number: 6605620Abstract: A cyclic amine compound by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.Type: GrantFiled: March 28, 2002Date of Patent: August 12, 2003Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Takeshi Doi, Yoshinori Kyotani, Masao Ohkuchi
-
Patent number: 6552188Abstract: Cyclic diamine compounds of formula (1) are disclosed: wherein A is (CH2)n, (CH2)n—CH═CH, CO—(CH2)n or CO—(CH2)n—CH═CH, in which n is a number of 0 to 3; Z represents a formula (2) or (3): in which R1, R2, R4, R5 and R6 are individually a hydrogen atom, alkyl group, alkoxy group, halogen atom or nitro group; R3is a hydrogen atom, alkyl group, alkoxy group, halogen atom, nitro group, naphthyl group, or phenyl group which may be substituted by 1 to 3 substituents selected from the group consisting of alkyl groups, alkoxy groups, halogen atoms, a nitro group and a phenyl group; and X and Y are individually CH or a nitrogen atom; and m is 1 or 2; an acid-addition salt thereof, or a hydrate thereof, and a medicine containing such a compound.Type: GrantFiled: June 29, 2001Date of Patent: April 22, 2003Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Takeshi Doi, Yoshinori Kyotani
-
Patent number: 6548656Abstract: This application provides frame-adjusting linkers FAL-1 and FAL-2 which are single-stranded DNA consisting of a palindrome base sequence of SEQ ID NO. 1 and SEQ ID NO. 2, respectively. These linkers are able to prepare mutant DNA sequences having correct translation frames before and behind the any cleaved sites, therefore, time and cost for preparation of mutant protein, etc. can be greatly reduced.Type: GrantFiled: November 26, 2001Date of Patent: April 15, 2003Assignee: Japan Science and Technology CorporationInventor: Toshiaki Oda
-
Publication number: 20030060461Abstract: A cyclic diamine compound of formula (1): 1Type: ApplicationFiled: June 29, 2001Publication date: March 27, 2003Applicant: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Takeshi Doi, Yoshinori Kyotani
-
Publication number: 20030022887Abstract: A cyclic diamine compound of formula (1): 1Type: ApplicationFiled: June 29, 2001Publication date: January 30, 2003Applicant: Kowa Co., Ltd.Inventors: Tatsuhiko Komada, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Shunji Takemura, Takeshi Doi, Yoshinori Kyotani
-
Patent number: 6509329Abstract: A cyclic diamine compound of formula (1): wherein A is a single bond or C≡C; X and Y are individually CH or a nitrogen atom; m is 1 or 2; and n is a number of 1 to 5; an acid-addition salt thereof, or a hydrate thereof. The compound has excellent inhibitory effects on both cell adhesion and cell infiltration and is useful as a medicine for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation.Type: GrantFiled: June 29, 2001Date of Patent: January 21, 2003Assignee: Kowa Co., Ltd.Inventors: Tatsuhiko Kodama, Masahiro Tamura, Toshiaki Oda, Yukiyoshi Yamazaki, Masahiro Nishikawa, Takeshi Doi, Yoshinori Kyotani